Aug 10, 2023

News & Events
Press Releases
Aug 8, 2023
Salarius Pharmaceuticals Announces Plans to Explore Strategic Alternatives and Implement Measures to Extend its Resources
Jul 11, 2023
Salarius Pharmaceuticals Receives FDA Clearance of SP-3164 Investigational New Drug Application to Begin a Phase 1 Clinical Trial in Relapsed/Refractory Non-Hodgkin Lymphoma Patients
Jun 12, 2023
Salarius Pharmaceuticals Presents SP-3164 Targeted Protein Degrader Preclinical Data at the European Hematology Association 2023 Hybrid Congress
Events
11th Annual Tumor Models Conference
EHA 2023 Hybrid Congress
BIO International Convention
AACR ANNUAL MEETING 2023
In the News
Precision Medicine Online